Skip to the content
Caishen.CoCaishen.Co
Primary Data for China's Secondary Investment and Stock Markets
  • Login
  • About
  • FAQ
  • Login
  • About
  • FAQ
  • Twitter
  • LInkedIn

Company: VCANBIO Cell & Gene Engineering Corp.

Financiers are optimistic about buying 4 shares, accounting for over 30% of the transaction_ Oriental Fortune Net

  • Post date May 17, 2022 — 10:25 Post Lock Login to View

Read More

Financiers are optimistic about the purchase of 3 shares, accounting for over 30% of the transaction_ Oriental Fortune Net

  • Post date May 9, 2022 — 10:55 Post Lock Login to View

Read More

Financiers are optimistic about the purchase of 3 shares, accounting for over 30% of the transaction_ Oriental Fortune Net

  • Post date May 5, 2022 — 10:50 Post Lock Login to View

Read More

Zhongyuan Xiehe (600645): Independent Opinions of the Independent Directors of Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd. on the 2021 Profit Distribution Plan- CFi.CN Zhongcai Network

  • Post date April 24, 2022 — 22:11 Post Lock Login to View

Read More

Zhongyuan Xiehe (600645): Resolution of the 17th Board Meeting of the Tenth Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd. CFi.CN Zhongcai Network

  • Post date April 24, 2022 — 22:11 Post Lock Login to View

Read More

Zhongyuan Xiehe (600645): Independent Opinions of the Independent Directors of Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd. on the 2021 Internal Control Evaluation Report- CFi.CN Zhongcai Network

  • Post date April 24, 2022 — 22:11 Post Lock Login to View

Read More

[Express] Zhongyuan Xiehe Announces Annual Report CFi.CN

  • Post date April 24, 2022 — 22:10 Post Lock Login to View

Read More

Zhongyuan Xiehe (600645): Notice of Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd. on Holding the 2021 Annual General Meeting of Shareholders- CFi.CN Zhongcai Network

  • Post date April 24, 2022 — 22:06 Post Lock Login to View

Read More

Zhongyuan Xiehe (600645): Revised Draft of the Raised Fund Management System of Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd. CFi.CN Zhongcai Network

  • Post date April 24, 2022 — 22:06 Post Lock Login to View

Read More

Zhongyuan Xiehe (600645): Independent opinion of the independent directors of Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd. on the provision of asset impairment losses- CFi.CN Zhongcai Net

  • Post date April 24, 2022 — 22:06 Post Lock Login to View

Read More

Zhongyuan Xiehe (600645): Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd. 2021 Internal Control Evaluation Report CFi.CN Zhongcai Network

  • Post date April 24, 2022 — 22:06 Post Lock Login to View

Read More

[Guarantee] Zhongyuan Xiehe (600645): The independent director of Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd.'s special explanation and independent opinion on the company's external guarantees and the funds occupied by related parties CFi.CN Zhongcai Network

  • Post date April 24, 2022 — 22:06 Post Lock Login to View

Read More

Zhongyuan Xiehe (600645): Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd. on the provision of asset impairment losses CFi.CN Zhongcai Network

  • Post date April 24, 2022 — 22:06 Post Lock Login to View

Read More

Zhongyuan Xiehe (600645): Resolution of the 10th Supervisory Committee Meeting of the 10th Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd. CFi.CN

  • Post date April 24, 2022 — 22:06 Post Lock Login to View

Read More

Zhongyuan Xiehe (600645): Special Explanation on the Occupation of Non-operating Funds and Other Related Fund Transactions of Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd. in 2021- CFi.CN Zhongcai Network

  • Post date April 24, 2022 — 22:06 Post Lock Login to View

Read More

Zhongyuan Xiehe: Deyuan Investment Pledge Extension of About 32.72 million shares_Oriental Fortune Net

  • Post date April 20, 2022 — 19:38 Post Lock Login to View

Read More

The pharmaceutical and biological industry fell 2.82% today, with a net outflow of 5.066 billion main funds.

  • Post date April 13, 2022 — 18:28 Post Lock Login to View

Read More

  • Twitter
  • LInkedIn
  • About Us
  • Contact Us
  • FAQ
  • Privacy Policy
  • Terms and Conditions
  • Corporate Subscription

Copyright © 2025 Caishen.Co. All rights reserved.

To the top ↑ Up ↑
China Money NetworkA service of China Money Network Ltd.